Open AccessThe role of SBRT in oligometastatic patients with liver metastases from breast cancer
Author(s) -
Marta Scorsetti,
Davide Franceschini,
Fiorenza De Rose,
Tiziana Comito,
Ciro Franzese,
Giovanna Masci,
Rosalba Torrisi,
Luca Viganò,
Guido Torzilli
Publication year - 2017
Publication title -
reports of practical oncology and radiotherapy
Language(s) - English
Resource type - Journals
eISSN - 2083-4640
pISSN - 1507-1367
DOI - 10.1016/j.rpor.2016.07.008
Subject(s) - medicine , breast cancer , radiosurgery , radiology , radiation therapy , liver cancer , oncology , cancer , disease
Liver metastases from breast cancer are a common occurrence. Local ablative therapies are a promising therapeutic option for these patients, with the potential for a long term disease control in the setting of "oligometastatic patients". Identification of the perfect candidate for local approaches is still challenging and unclear. Stereotactic body radiation therapy (SBRT) is one of the most valuable local therapy, because of great efficiency, low morbidity and minimal invasiveness. In this paper, we reviewed the state of the art in the care of breast cancer patients with liver metastases, with a focus on SBRT.